Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer

Recruiting now · Not applicable

Conditions studied: Children With Cancer

In brief

This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.

Key facts

Study ID

NCT05922553

Run by

Wei XIA, PhD

People needed

124

Starts

2024-12-16

Expected to finish

2026-06-01

Last updated by the study team

2025-08-06

Who can join

Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged between 6 to 18 years old;
• Children in accordance with the guidelines for the Diagnosis and Treatment of 12 Diseases related to hematologic diseases and malignant tumors (2021 version) issued by the General Office of the National Health Commission;
• At least experience one full cycle of chemotherapy;
• Children with moderate or higher symptoms of decreased appetite were screened for a list of treatment-related symptoms.

You may not qualify if…

• Children with serious cardiopulmonary disease, infection, organ damage, or genetic metabolic disease, immune deficiency disease, mental illness;
• Children with eye or ear dysfunction that prevents them from watching and listening to videos.

Where it is running

• Sun Yat-sen Memorial Hospital — Guangzhou, Guangdong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.